Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition

Overview

About this study

This study is being implemented to identify the role of prophylactic use of ethanol lock in adult patients on home parenteral nutrition (HPN). Central catheter related blood stream infection is a major complication in patients on HPN. The investigators hypothesize that the prophylactic use of ELT will decrease the number of catheter related blood stream infections compared to the control group. The investigators further hypothesize that with the introduction of prophylactic ELT, the number of infections will decrease. This will improve the quality of life (assessed using Questionnaire) in HPN patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Newly started on Home parenteral Nutrition and anticipated duration >3 months.
  • Not previously on Home Parenteral Nutrition.
  • Providing consent.
  • Patients with non-medicare insurance.
  • Patients with medicare insurance and a supplementary insurance.
  • Patients with single lumen Hickman® catheters.
  • No known alcohol addiction.

Exclusion Criteria:

  • Failure to provide consent
  • Patients with medicare insurance and no other supplemental private insurance
  • Patients with a catheter type other than a single lumen Hickman®
  • Patients who are on HPN for less than three months
  • Pregnant patients
  • Patients who have previous proven addiction and dependence to alcohol.
  • Patients lacking capacity to provide consent
  • Patients who are not be managed by HPN team at investigator's institution

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ryan Hurt, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20118923

Mayo Clinic Footer